Michael Gelband’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$379K Sell
99,236
-84,740
-46% -$410K ﹤0.01% 1304
2026
Q1
$975K Buy
183,976
+79,029
+75% +$487K 0.01% 1011
2025
Q4
$810K Buy
104,947
+69,047
+192% +$615K 0.01% 1066
2025
Q3
$317K Buy
+35,900
New +$267K ﹤0.01% 1291
2024
Q4
Sell
-72,061
Closed -$215K 2106
2024
Q3
$215K Buy
+72,061
New +$196K ﹤0.01% 1440
2024
Q2
Sell
-14,752
Closed -$174K 2020
2024
Q1
$174K Sell
14,752
-36,627
-71% -$423K ﹤0.01% 1371
2023
Q4
$418K Buy
+51,379
New +$369K ﹤0.01% 1085
2022
Q1
Sell
-3,982
Closed -$98K 2717
2021
Q4
$98K Buy
+3,982
New +$126K ﹤0.01% 1956
2021
Q3
Sell
-907
Closed -$44K 2685
2021
Q2
$44K Sell
907
-2,575
-74% -$107K ﹤0.01% 2232
2021
Q1
$103K Buy
3,482
+1,842
+112% +$51.6K ﹤0.01% 1975
2020
Q4
$42K Buy
+1,640
New +$32.9K ﹤0.01% 1879
2020
Q3
Sell
-1,838
Closed -$38K 2268
2020
Q2
$38K Sell
1,838
-4,470
-71% -$118K ﹤0.01% 1693
2020
Q1
$200K Buy
6,308
+4,998
+382% +$125K 0.01% 792
2019
Q4
$21K Buy
+1,310
New +$18.8K ﹤0.01% 1467

Other funds holding VSTM

Michael Gelband's VSTM Position: Q2 2026 in Review

Michael Gelband reduced its Verastem (VSTM) stake by 46% in Q2 2026, selling an estimated $410K and leaving 99,236 shares worth $379K. The position accounts for ﹤0.01% of the portfolio, ranked #1304.

Michael Gelband first reported a position in VSTM in Q4 2019 and has held it in 14 quarters since. The position peaked at $975K in Q1 2026. 156 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Michael Gelband held 99,236 shares of Verastem worth $379K as of Q2 2026.
  • Michael Gelband sold 84,740 Verastem shares in Q2 2026, an estimated $410K.
  • Verastem made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1304 holding.
  • Michael Gelband first reported a position in Verastem in Q4 2019 and has held it in 14 quarters since.
  • Michael Gelband's Verastem position peaked at $975K in Q1 2026.
  • 156 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.